Secure Storage of Blood Fraction Samples
Biobank Uppsala, a leading Scandinavian biobank, has reported on its use of 2D-coded sample storage tubes, racks and caps from Micronic to provide traceable, high integrity storage of blood fraction samples (mainly serum and plasma).
Uppsala Biobank began its operations in September 2008 and is a collaboration between Uppsala County Council, as represented by Uppsala University Hospital, and Uppsala University (Faculty of Medicine). Uppsala Biobank was founded to provide an organized central collection of samples that are gathered, stored and registered for the purpose of being conserved for scientific studies, treatment, and investigations.
Maria Storgärds, Project Leader at Uppsala Biobank commented: “We have about 80,000 aliquots stored today. Our collection is increasing by approximately 4000 aliquots per month indicating the number of stored samples will be at least doubled within 2–4 years.”
She continued: “Our aim is to ensure blood, plasma and serum samples are processed from patient to cold storage in our biobank in less than 4 hours. However in a 4-hour period we seldom have 12 new samples (96 aliquots) to store. Because of this the ability of the Micronic Capcluster system to securely cap a single tube, a row of tubes or even a complete 96-tube rack in a single action perfectly suited us". She added: "The low profile of Micronic 96-tube storage racks and compact size of their 0.50 mL 2D-coded tubes has allowed us to optimize use of our valuable freezer space and usefully is also fully automation compatible".
Micronic 0.50 mL sample storage tubes are manufactured from medical grade polypropylene, according to US and European Pharmacopoeia tests, in a classified Class 7 cleanroom environment ensuring they exhibit absolute product consistency, near zero contaminants and are RNase/DNase free. The tubes resist many organic solvents (DMSO, methanol, dichloromethane), may be autoclaved, withstand gamma rays used for sterilisation and can be repeatedly freeze-thawed. A unique 2D code non-detachable laser etched onto the bottom of each tube provides an easy and unambiguous means of storing and identifying samples. The optimized internal shape of each Micronic sample storage tube ensures the lowest possible dead volume and maximum sample recovery.
For further information relating to Uppsala Biobank please visit www.uppsalabiobank.uu.
For further information on sample storage solutions for biobanking applications please contact Micronic Europe B.V. (Asia, Africa, Europe and Oceania) now on +31 320 277070/email [email protected] or Micronic America LLC (North, Central and South America) on +1 484 480 3372.
Related News
-
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs... -
News Chasing new frontiers at LEAP – The National Biotechnology Strategy Keynote
On the third day of LEAP (4–7 March 2024, Riyadh Exhibition and Convention Centre, Malham, Saudi Arabia) the CPHI Middle East team hosted the Future Pharma Forum, to set the scene for an exciting new event for the pharma community, coming to Riya... -
News Pfizer maps out plans for developing new oncology therapeutics by 2030
Pfizer dilvulges plans to investors around growing their cancer portfolio, and the drugs they will be focusing on developing after their aquisition of Seagen in 2023. -
News Generics threat to Merck’s Bridion as Hikma seeks pre-patent expiry approval
Merck has disclosed they received notice from Hikma Pharmaceuticals for seeking a pre-patent expiry US FDA approval for Hikma’s generic version of Merck’s Bridion. -
News Bernie Sanders vs Big Pharma - the latest on drug price negotiations
In a hearing in front of the US Senate, three of the biggest pharmaceutical companies in America are challenged over exorbitant prescription drug prices, with Sanders claiming their actions are limiting the population's access to affordable healthc...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance